Clinical Trials on Electrophilic Fatty Acids in Belgium

Total 96 results

KU Leuven

Completed

Determination of the Bioavailability of Short Chain Fatty Acids in Healthy Humans

Short Chain Fatty Acids Bioavailability

Belgium
KU Leuven

Recruiting

The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers (Sistine)

Metabolism | Intestinal Absorption | Systemic Availability | Short-chain Fatty Acids

Belgium
Reneo Pharma Ltd

Completed

A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders (FORWARD)

Fatty Acid Oxidation Disorder

United States, Spain, France, Austria, Poland, Belgium, Czechia, Denmark, Hungary, Italy, United Kingdom
Hasselt University

Recruiting

Screening for NAFLD in Flanders

Non-Alcoholic Fatty Liver Disease

Belgium
Ziekenhuis Oost-Limburg

Recruiting

Lifestyle Guidance Methods in NAFLD (INDIANA)

Non-Alcoholic Fatty Liver Disease

Belgium
Hasselt University

Active, not recruiting

Economic Burden of NAFLD

NAFLD | Non-Alcoholic Fatty Liver Disease

Belgium
Erasme University Hospital
Epidemiological and Clinical Research Information Network

Recruiting

Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis. (ENDONASH)

NASH - Nonalcoholic Steatohepatitis

Belgium
Erasme University Hospital
Fractyl Laboratories, Inc.

Completed

Effect of DMR in the Treatment of NASH (DMR_NASH_001)

NASH - Nonalcoholic Steatohepatitis

Belgium
GlaxoSmithKline

Completed

Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects

AIDS | AIDS Vaccines

Belgium
Oramed, Ltd.

Completed

A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis (NASH)

Belgium
Ziekenhuis Oost-Limburg
Ziekenhuis Oost-Limburg

Recruiting

Characteristics of NAFLD Among Type 2 Diabetes Patients

Type2 Diabetes | Non-Alcoholic Fatty Liver Disease

Belgium
Diafir
Clinact

Completed

Signature Diagnostic of Non-alcoholic Steatohepatitis (NASH) by Infrared Light Spectroscopy (SIGNALS)

Obesity

Belgium
ViiV Healthcare
Pfizer

Completed

Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc

AIDS

Belgium
University Hospital, Ghent

Recruiting

Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease

Pediatric Non-alcoholic Fatty Liver Disease

Belgium
GlaxoSmithKline

Completed

Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose

AIDS

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Acid Suppressive Therapy - Review of Appropriateness (ASTRA)

Appropriate Startup of Acid Suppressive Therapy

Belgium
University Hospital, Antwerp

Recruiting

Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus (NAFLDIA1)

Cardiovascular Diseases | Type 1 Diabetes | NAFLD

Belgium
Promethera Therapeutics

Completed

Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients (PANASH)

NASH - Nonalcoholic Steatohepatitis

Spain, Belgium, Bulgaria, France
Alnylam Pharmaceuticals

Terminated

A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis | NASH

United States, Bulgaria, United Kingdom, Belgium, Turkey
Meridian Bioscience, Inc.

Completed

BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH

Non-Alcoholic Steatohepatitis

United States, France, Belgium, United Kingdom
KU Leuven

Active, not recruiting

Acute Effect of Exogenous Ketosis on Sleep Architecture Following Strenuous Exercise

Sleep

Belgium
Erasme University Hospital

Completed

Do Anesthesiologists Follow Guidelines on Perioperative Use of Tranexamic Acid? (Periop_TXA)

Blood Loss, Surgical | Blood Transfusion | Tranexamic Acid

Belgium
KU Leuven

Active, not recruiting

Role of Intermittent Exogenous Ketosis in the Physiological and Muscular Adaptive Response to Endurance Training

Exercise Adaptations

Belgium
Universitair Ziekenhuis Brussel

Unknown

Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy

Acid Reflux Esophagitis | Non-acid Reflux Esophagitis

Belgium
University Hospital, Ghent

Recruiting

Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass (LABOR)

Hypoglycemia | Gastric Outlet Obstruction | Steatohepatitis | Gastric Bypass | Parenteral Support

Belgium
Boehringer Ingelheim

Completed

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

Non-alcoholic Fatty Liver Disease

United States, Spain, United Kingdom, Belgium, Canada, Germany, Netherlands, France, Ireland
Astellas Pharma Inc

Completed

A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831 (ASTER)

Non-Alcoholic Steatohepatitis

United Kingdom, Belgium, Switzerland, Germany, France, Romania, Czech Republic
KU Leuven

Active, not recruiting

Effect of Exogenous Ketosis During Ultra-endurance Exercise

Exercise | Cognitive Function | Ketosis | Skeletal Muscle | Ultra-endurance Running

Belgium
Merck Sharp & Dohme LLC

Recruiting

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

Non-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Fatty Liver, Nonalcoholic

Canada, United States, Puerto Rico, Japan, Korea, Republic of, Taiwan, Spain, Israel, Chile, France, Italy, Hungary, Switzerland, Belgium, China, Singapore, Czechia, Portugal, Austria, United Kingdom, Thailand, Hong Kong, Turkey, Colo... and more
Centre Hospitalier Universitaire Saint Pierre
Fonds iris-Recherche, Fondation Roi Baudouin, Belgium

Completed

Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder (OCT-HIV)

AIDS-Related Dementia Complex

Belgium
Enyo Pharma

Completed

Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)

Non-alcoholic Steatohepatitis

United States, Belgium, France, Puerto Rico, United Kingdom
GlaxoSmithKline

Recruiting

Phase 2b Study of GSK4532990 in Adults With NASH (HORIZON)

Nonalcoholic Fatty Liver Disease

United States, Australia, Italy, Japan, Spain, Belgium, Argentina, Canada, United Kingdom, Korea, Republic of, France, Greece, India, Mexico, Puerto Rico, Turkey, Panama
Genentech, Inc.

Terminated

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis (BANFF)

Non-alcoholic Steatohepatitis

Belgium, United States, Spain, Puerto Rico, France
University Hospital, Ghent

Completed

Uremic Toxins in the Intensive Care Units (ICU): Patients With Lactate Acidosis

Acute Renal Failure

Belgium
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) (SYNERGY-NASH)

Nonalcoholic Steatohepatitis

United States, Spain, Japan, United Kingdom, Belgium, France, Italy, Israel, Mexico, Poland
Jozef Stefan Institute
KU Leuven; University of Lausanne

Active, not recruiting

Intermittent Exogenous Ketosis (IEK) at High Altitude

Hypoxia | Ketosis

Belgium, Slovenia
Sanofi

Terminated

An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes

Fatty Liver

United States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
Sanofi

Terminated

An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes

Fatty Liver

United States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
Novo Nordisk A/S

Active, not recruiting

Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

Non-alcoholic Steatohepatitis

Spain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
GlaxoSmithKline

Completed

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

HIV Infections | AIDS

Belgium
NGM Biopharmaceuticals, Inc

Completed

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

Nonalcoholic Steatohepatitis | Compensated Cirrhosis

United States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
Novo Nordisk A/S

Recruiting

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) (ESSENCE)

Non-alcoholic Steatohepatitis

United States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Switzerland, Ireland, Belgium, Romania, Ger... and more
Universitaire Ziekenhuizen KU Leuven

Unknown

Renal Tubular Acidosis in Incident Renal Transplant Recipients

Renal Transplant Disorder

Belgium
Genfit
Premier Research Group plc; Naturalpha

Completed

Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis (NASH)

United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
Novartis Pharmaceuticals

Terminated

Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) (FLIGHT-FXR)

Non-alcoholic Steatohepatitis (NASH)

Belgium, Germany, Taiwan, Austria, United States, Spain, Korea, Republic of, Argentina, Australia, Italy, Japan, Singapore, Netherlands, Slovakia, France, Canada, India
Novo Nordisk A/S

Completed

Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.

Non-alcoholic Steatohepatitis | Hepatobiliary Disorders

United States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
Gilead Sciences

Terminated

Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (STELLAR-4)

Nonalcoholic Steatohepatitis

United States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland
Viking Therapeutics, Inc.

Active, not recruiting

A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH (VOYAGE)

NASH - Nonalcoholic Steatohepatitis

United States, Belgium, France, Mexico, Puerto Rico
Inventiva Pharma

Completed

Phase 2b Study in NASH to Assess IVA337 (NATIVE)

Non-Alcoholic Steatohepatitis (NASH)

United States, Spain, United Kingdom, France, Belgium, Austria, Switzerland, Australia, Germany, Slovenia, Bulgaria, Canada, Czechia, Italy, Mauritius, Poland
Gilead Sciences

Terminated

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis (STELLAR-3)

Nonalcoholic Steatohepatitis

Hong Kong, United States, Spain, United Kingdom, Australia, Taiwan, Belgium, Canada, India, Japan, Korea, Republic of, Singapore, Puerto Rico, France, Israel, Austria, Germany, Italy, Malaysia, New Zealand, Mexico, Poland, Switzerland, Netherlan... and more

Clinical Trials on Electrophilic Fatty Acids in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations